Screening for tuberculosis (TB) disease aims to improve early TB case detection. The ultimate goal is to improve outcomes for people with TB and to reduce Mycobacterium tuberculosis transmission in the community through improved case detection, reduction in diagnostic delays and early treatment. Before screening programmes are recommended, evidence is needed of individual and/or community-level benefits.
questions. Screening increases the number of cases found in the short term. In many settings, more than half of the prevalent TB cases in the community remain undiagnosed. Screening tends to find cases earlier and with less severe disease, but this may be attributed to casefinding studies using more sensitive diagnostic methods than routine programmes. Treatment outcomes among people identified through screening are similar to outcomes among those identified through passive case finding. Current studies provide insufficient evidence to show that active screening for TB disease impacts on TB epidemiology. C O N C L U S I O N : Individual and community-level benefits from active screening for TB disease remain uncertain. So far, the benefits of earlier diagnosis on patient outcomes and transmission have not been established. K E Y W O R D S : screening; impact evaluation; mortality; transmission INVESTMENTS in tuberculosis (TB) control on a global scale have resulted in reductions in prevalence and deaths due to TB. However, TB case detection has stagnated in recent years, while estimated TB incidence is declining very slowly. This has resulted in renewed interest in the potential contribution to early case detection from systematic TB screening. TB screening in human immunodefi ciency virus (HIV) infected individuals has been recommended by the World Health Organization (WHO) as part of the 'Three I's' policy initiative. 1,2 Although systematic screening of household contacts of infectious TB cases has been recommended, [3] [4] [5] population-wide mass screening has been discouraged due to its uncertain impact, high cost and poor sustainability. [6] [7] [8] There has recently been a renewed interest in systematic screening for active TB disease among risk groups as well as population-wide screening interventions.
National TB prevalence surveys have demonstrated that a large pool of undetected prevalent cases exists even in settings with well-functioning TB programmes, and many of these prevalent cases would have been diffi cult to reach with passive case fi nding (PCF) approaches. [9] [10] [11] Several recently launched screening initiatives have shown promising results. 6, 12, 13 The ultimate goal of systematic TB screening is to improve health outcomes among people with TB and reduce Mycobacterium tuberculosis transmission in the community through improved TB detection, reduction in diagnostic delays and early treatment. 7 The impact evaluation of TB control interventions, however, is technically diffi cult and expensive, and is thus rarely included in programmatic or research studies.
Before screening programmes are recommended, evidence is needed of individual or community-level benefi ts from early diagnosis provided by screening, and that any benefi ts outweigh any harms incurred. We reviewed the evidence of individual and/or community benefi ts from active TB screening, focusing on additional TB cases detected, reduction in diagnostic delay, improved treatment outcomes and impact on TB epidemiology.
METHODS

Definitions
We defi ned screening for active TB as the systematic identifi cation of people with suspected active TB in a predetermined target group by the application of tests, examinations or other procedures. Among those with suspected TB, diagnosis needs to be established through the application of one or several diagnostic tests and clinical assessment. Screening can be done either as an outreach activity in the general community, among TB contacts and in other specifi c highrisk groups, or among people seeking care, including those who seek care for reasons other than symptoms compatible with TB. The latter category includes, for example, people attending for regular check-up of conditions that are risk factors for TB, such as HIV and diabetes. Passive case fi nding (PCF) is defi ned as the detection of active TB disease among symptomatic patients who self-present to medical services for the diagnosis of symptoms, with a specifi c focus on people with typical TB symptoms, such as chronic cough. Active case fi nding (ACF) implies screening through outreach activities outside health services. Enhanced case fi nding (ECF) primarily aims to make a population aware of TB symptoms through publicity and education, and encourages self-presentation to medical services, which may be decentralised as part of the intervention. This in effect means that ECF is PCF combined with intensifi ed health information. 7 However, ECF can also include a screening element, for example as part of a chest/health camp, in which case the intervention is a combined ACF/ECF intervention. In this paper, we will use 'screening' to describe ACF interventions and ECF for interventions that mainly focus on health information.
Specific questions
The review addressed four specifi c questions:
1 Does screening for TB disease increase the number of TB cases detected compared to PCF? 2 Does screening for TB disease identify cases at an earlier stage of TB disease than PCF? 3 Is there a difference in treatment outcomes between TB cases found by screening and those found through PCF? 4 Does the addition of screening for TB disease to PCF affect TB incidence or prevalence in the community?
The questions were defi ned in 2011 in the scoping meeting for the development of TB screening guidelines held by the Stop TB Department. 8 A detailed study protocol and a data extraction form were developed.
Inclusion criteria
Inclusion criteria for studies addressing the four questions are outlined below.
Does screening for tuberculosis disease increase case detection?
Studies should ideally be longitudinal, with continuous or repeated rounds of screening in addition to PCF, to report the number of cases detected by screening and PCF over time. This would allow the effects of screening to be assessed beyond the fi rst round, in which a large number of long-term undetected cases may be found. However, due to the paucity of such studies, the inclusion criteria were widened to include cross-sectional studies of one-off screening reporting the number or proportion of TB cases detected by screening and passively, and prevalence surveys reporting the proportion of undiagnosed TB.
Does screening for tuberculosis disease identify cases earlier?
All studies comparing at least one of 1) the length of time between reported onset of symptoms and start of treatment, 2) sputum positivity rate, or 3) chest X-ray (CXR) abnormalities at time of diagnosis in TB cases detected through screening and passively were eligible. Contact tracing studies were eligible if the index cases were representative of all TB cases detected passively (so that they could form the comparison group).
Does screening for tuberculosis disease affect treatment outcome?
Studies should ideally allow direct comparisons of outcomes of patients identifi ed actively or passively in the same area. However, as there were few such studies, we included all studies reporting on outcomes of TB cases identifi ed actively for comparison with WHO target outcomes.
Does screening for tuberculosis disease affect tuberculosis epidemiology?
All studies comparing TB prevalence, incidence or transmission in communities receiving screening and PCF, and in communities receiving PCF only, were eligible. Studies investigating impact in specifi c groups (such as prisons, mines or risk groups) that did not investigate the impact on the general population were excluded. Study designs could be before-after comparisons, cluster randomised controlled trials or quasiexperimental designs.
Search strategy
The initial search used papers selected on initial screening by an existing systematic review 14 which had already identifi ed TB case-fi nding studies published up to 13 October 2010. The review by Shapiro et al. searched online databases PubMed, EMBASE and SCOPUS from 1980 to 2010 to identify titles and abstracts of peer-reviewed papers that met the criteria for initial review. The detailed search strategy is outlined in Appendix Table A.1.* Titles and abstracts identifi ed by the search terms were entered into a database, duplicates were eliminated and the remaining entries were independently screened by two readers for inclusion in the next stage of review. Discrepancies were resolved by consensus and/or consultation with a third reader. Initial review criteria were very broad, and required only that the publication be original research (i.e., not a review, commentary or author reply letter); titles, abstracts or key words suggest that screening took place. Titles and abstracts were included for further review if a determination could not be made at this stage. Studies that screened only for TB infection and not active TB, such as the annual risk of TB infection, were excluded. Papers and abstracts in English, Spanish, French, Russian and Japanese were included; other languages were excluded. In addition to online databases, abstracts from 2008-2010 of the conferences of the International AIDS Society (AIDS/IAS), the International Union Against Tuberculosis and Lung Disease and the American Thoracic Society were searched to identify the most recent research conducted on screening strategies.
No exclusions were made on the basis of study population, geographical setting or year of publication. This review identifi ed a total of 827 publications and abstracts: 759 were published in English, 20 in Spanish, 25 in Japanese and 23 in Russian. In addition, data from prevalence surveys provided by the WHO were added, together with further papers identifi ed by experts in the fi eld and unpublished data from the recently completed ZAMSTAR (Zambia South Africa TB and HIV Reduction) study. As treatment outcome data might be published separately from the initial screening results, additional searches were undertaken to identify subsequent publications reporting anti-tuberculosis treatment outcomes of all studies with at least 40 TB cases identifi ed through screening and published after 1992 (when DOTS became widely available). Searches used Ovid Medline using the fi rst or the last authors' names combined with 'treatment outcomes' and 'tuberculosis'. In addition, fi rst and last authors of studies published between 2005 and 2011 were contacted directly.
Selection of publications for inclusion
The full texts of all publications identifi ed by Shapiro et al. were screened for relevance for any of the four outcomes. This was done in stages: an initial screen to check for possible eligibility, then a more detailed screening of retained papers, followed by data extraction of eligible publications. The fi rst 120 publications reviewed in the initial screening were done in duplicate to ensure consistency, and all data extraction of included papers was done in duplicate using a standardised data extraction tool. Any discrepancies were resolved by discussion.
Data synthesis and analysis
Settings, populations (e.g., homeless, refugees, general population) and screening approach differed considerably. Due to the heterogeneity of the studies, a narrative approach was adopted for data synthesis. A formal meta-analysis was conducted where appropriate, which was only for the treatment outcome analysis. The relative risk (RR) of successful treatment by case-fi nding method was calculated and pooled with the DerSimonian-Laird random-effects method, which treats studies as a sample of all potential studies, and incorporates an additional between-study component to the estimate of variability. The I 2 statistic was calculated as a measure of the proportion of the overall variation that is attributable to betweenstudy heterogeneity.
Quality assessment
The vast majority of the studies included in this review are observational. Furthermore, while comparisons are often made between actively and passively found groups, details of these groups that would enable an assessment of comparability, such as baseline characteristics, are often absent.
The GRADE (Grades of Recommendation, Assessment, Development, and Evaluation) guidelines identify four key limitations that can lead to a risk of bias in observational studies: [15] [16] [17] 1) failure to develop and apply appropriate eligibility criteria, 2) fl awed measurement of both exposure and outcome, 3) failure to adequately control confounding, and 4) incomplete follow-up. In the context of this review, such limitations were assessed for each of the questions being evaluated.
Thus, for question 1-the yield of TB cases identifi ed from screening-an assessment of quality was based upon 1) the extent to which study fi ndings can be applied to the broader population from which the study sample was drawn, and 2) the standard of diagnosis of active TB for both actively and passively found cases. Specifi c aspects of each study that were assessed include the sampling method, the sample size, the inclusion/exclusion criteria of participants, the level of non-participation, the method by which active TB was diagnosed and the nature of the quality control of TB diagnosis.
For question 2, which compares disease progression in groups found through screening and passively found groups, quality assessment was based upon 1) details given of prognostic factors in both groups, and 2) the standard of diagnostic measures used to assess the nature and duration of symptoms.
For question 3-assessment of TB outcomesquality assessment was based on the methods used to ascertain outcomes. Specifi c measures included the method by which death was notifi ed, efforts made to trace lost to follow-up and defaulting patients, and the methods by which TB cure was established and verifi ed.
For question 4, in which changes in the epidemiology of TB were being assessed, studies could be randomised controlled trials, prevalence surveys or quasi-experimental designs. The quality assessment varied according to the nature of the study, but particular attention was paid to methods for assessing trends in incidence/prevalence (e.g., surveys or routine notifi cation).
RESULTS
Identification of studies
A total of 31 915 publications and 79 abstracts were identifi ed in the previous search. In addition, we reviewed unpublished studies and studies identifi ed through expert opinion, prevalence surveys from Cambodia and Myanmar and conference abstracts and unpublished reports from the ZAMSTAR study, and identifi ed 21 relevant studies; 1811 publications were identifi ed for full-text review after removal of duplicates and screening of the titles and abstracts. Of these, 963 were excluded on an initial screen and 786 subsequently, leaving 62 publications that addressed at least one of the study questions (Appendix Figure) .
Studies covered a range of different populations and used a variety of screening algorithms. Details are summarised in Appendix Table A.2. Screening included symptoms, CXR and sputum for smear microscopy and/or culture. A key distinction is whether the methods were used sequentially or together and, in particular, whether only symptomatic cases were screened further or whether the initial screen included bacteriology or X-ray even among asymptomatic cases (thus increasing the sensitivity of the screen).
Does screening for tuberculosis disease increase the number of tuberculosis cases detected?
Studies assessing the contribution of screening over time One recent study and two historical studies were identifi ed in which the proportion of cases identifi ed through screening could be assessed over time. In Morocco, household contacts were screened for TB. 18 National fi gures were reported from 1993 to 2004, involving more than one million identifi ed contacts. In this context, with different individuals involved in screening every year, no change in the proportion found due to removal of prevalent cases is expected. The proportion of TB in the population detected through this screening averaged 5.6% and decreased slightly over time; this decrease may be attributed to a fall in the ratio of household contacts screened to index cases over time.
In a district in Czechoslovakia, mass miniature radiography (MMR) surveys with >95% coverage were carried out every 3 years from 1960 (together with bacilli Calmette-Guérin vaccination of newborns and revaccination of adolescents), while screening was also performed during regular check-up of people with previously known CXR lesions. 19 The prevalence of smear-and/or culture-positive TB was 73/100 000 at the beginning of the study and had declined to 56/100 000 by 1972. The total number of smear-and/or culture-positive TB cases was 79 Over the whole period, the contribution of MMR was 102/379 cases (27%), which was similar to the contribution of other screening approaches (108/379, 28%).
In the Netherlands, MMR surveys were initiated in 1941. 20 A quarter to a third of the adult population was examined each year. In addition, individuals with fi brotic lesions, recent TB contacts and tuberculin skin test (TST) converters were regularly followed. The studies from Czechoslovakia and the Netherlands were conducted before the DOTS strategy and standard short-course treatment regimens became available. The screening algorithm applied to individuals with positive CXR was not described, but as cases were disaggregated by both smear and culture status, all patients were most likely investigated with both tests. The Czech study achieved very high coverage at 3-yearly screening intervals, while the Dutch study screened continuously, with lower coverage. Both studies show a reduction in smear-and/or culture-positive TB cases, but this may refl ect underlying secular trends and/or the combined effect of screening and PCF. The contribution of ACF to the overall number of cases remained high in the Netherlands, but decreased substantially from very high initial levels in Czechoslovakia. Both studies used both MMR surveys and CXR screening in specifi c high-risk groups, notably people with CXR lesions identifi ed in previous screenings, and the contribution by the two screening approaches was similar in both countries. Recent communitybased screening programmes in high-prevalence countries have mainly relied on symptom screening, sputum smears and culture, partly due to the logistical and operational challenges of mass CXR screening. 6, 21 It is diffi cult to assess how the results from these two historic studies compare with the current situation in high TB prevalence countries. Despite these limitations, these are the only studies evaluating mass screening activities over prolonged periods of time.
Cases identifi ed in trials of screening
Four randomised trials were identifi ed that investigated the effect of screening on TB case fi nding, all over a short time period (Table 1) . They compared TB case notifi cation rates among communities or individuals actively screened or not screened. Different interventions were used, as summarised in the Table. In Brazil, door-to-door screening increased the case yield during the intervention, but not overall during the whole period of the study, so the effect seemed to be on delay rather than on the total number diagnosed. 25 The Ethiopian studies used community health workers in different ways to increase awareness, case fi nding and diagnosis, and were thus ECF interventions with a screening element. One of the Ethiopian studies used prea dvertised outreach clinics, 22 whereas the other implemented a combination of increased awareness, facilitation of sputum collection and treatment support. 23 Both found higher case rates in the intervention communities. The South African study followed a cohort of infants randomised to screening or PCF, and found that screening increased case fi nding by 2.6 times. 24 All of these studies were large cluster randomised trials, except for the trial in infants. All used smearpositive patients diagnosed at the local clinics as the outcome. The Ethiopian study conducted in 2003 22 did not describe the method for choosing which communities received the intervention. Few baseline comparison data are given, but the map suggests a 
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437 non-random selection and differences between intervention and control communities. As the communities were contiguous, there could be contamination. The intervention was through community promoters, encouraging presentation and sputum collection at outposts, and not house-to-house screening. The analysis took the clustering into account. There was a small increase in cases found. The other Ethiopian study described the method of randomisation, but few baseline comparison data are given. 23 The areas were contiguous. In intervention communities, health extension workers based at health posts encouraged symptomatic individuals to present and took sputum samples. Although they were called case-detection rate, the results presented appear to be prevalence and difference in prevalence, adjusted for the clustering. There was an increase in cases detected in the intervention communities. The Brazilian study used paired communities, matched by TB case notifi cation rates, and random allocation of intervention between the pairs. 25 Intervention communities were smaller, with a higher proportion of women. The intervention communities received house-to-house visits enquiring about cough and collecting sputum if symptomatic: 71% of identifi ed households were enrolled. The control communities received pamphlets with information on TB and encouraging attendance at health centres. The analysis took pairing and clustering into account. The results showed an increase in case fi nding during the short period of the intervention, but not overall.
Prevalence surveys
Prevalence surveys provide an estimate of the burden of undiagnosed TB, which could potentially be diagnosed by systematic TB screening. These surveys are summarised in Appendix Table A .3. They vary in scope from small studies in high-prevalence areas to national surveys. The prevalence of TB varied considerably between studies, but the proportion of previously undiagnosed TB was high in all, 35-85% of cases. Recent surveys have calculated the 'patient diagnostic rate' (reported cases/100 000/year divided by prevalence/ 100 000). Higher numbers imply a faster rate of diagnosis (less undiagnosed TB), but exactly how this relates to the proportion of cases detected depends on the duration of untreated TB. 37 Many of these studies were large, covered randomly selected representative populations and included a high proportion of eligible individuals (although this was not always stated). Screening algorithms varied (Appendix Table A .2) and would have had varying sensitivity. Case defi nitions also varied, and culture was only available in some settings. As shown by the study in Cambodia, the proportion of cases undiagnosed is crucially dependent on the defi nition used. The case defi nitions used for those already on treatment were not usually given. The number on treatment sometimes depended on reports by the individuals, sometimes on verifi cation of registers and sometimes on notifi cations, but, as illustrated in the Ethiopian studies, 23, 29 there could be considerable discrepancy between reports and registers. In all studies, the number on treatment is an underestimate of the period prevalence of diagnosed TB, as only survivors and non-hospitalised patients were included.
Contribution of screening to total number of tuberculosis cases diagnosed
In addition to the longitudinal studies cited above, a total of 14 studies provided data on the contribution of screening to the total TB cases diagnosed (Appendix Table A .4). These included studies of home visits to higher-risk members of the community, outreach screening combined with information activities in the community, contact screening or clinic screening. Community-based studies that covered a high proportion of the total community found a substantial proportion of the total cases. In contrast, studies targeting specifi c groups contributed relatively few cases. Notably, none of the studies of contacts, even those from low-prevalence areas, contributed >9% of the total cases identifi ed. Screening algorithms varied widely, and the TB case defi nitions used to estimate the total number of TB cases diagnosed in the region were not clear. It was thus diffi cult to draw fi rm conclusions.
As the studies included here addressed different issues, an overall assessment of quality is not really appropriate. Some of the issues discussed above apply: the screening algorithms varied, the defi nitions used for the estimate of prevalence in the region were not clear. Contact tracing studies were most comparable, although the settings and background incidence of TB varied considerably; therefore, the proportion of total TB in the area that occurs in contacts is not expected to be consistent, whether or not ACF is used.
Does screening for tuberculosis disease identify cases earlier?
Several studies compared delay to treatment or extent of disease at presentation between those identifi ed through screening and PCF ( Table 2 ). All studies found that those who were identifi ed through screening were more likely to be at an earlier stage of disease: they were less likely to be smear-positive, had a lower degree of smear positivity and were less likely to have severe CXR changes such as cavitation. There was less direct evidence of a difference in duration of symptoms, but there was a marked shortening of delay in the only large study to measure it. 44 In addition, in the case-fi nding intervention trial in Ethiopia, 22 patients from communities with the intervention had shorter delays than those in comparison communities. In the Brazilian trial, at the community level there was little difference in the delay, with the door-to-door intervention group having a mean delay of 57 days (95%CI 33-82) compared to the pamphlet group, which had a mean delay of 53 days (95%CI 38-68). 25 However, the short-term increase in case fi nding during door-to-door screening, but not subsequently, suggests a reduction in delay for these cases (Table 1) . A diffi culty in assessing these studies is to know what diagnostic procedures were applied to passively detected cases. Unfortunately, these data were not available for the majority of the studies ( Table 2 ). The proportion of smear-positive cases was consistently lower among cases identifi ed through screening and ECF than among passively found cases, but this would be expected if smear is the main method of routine diagnosis in PCF, as was the case in South Africa, where culture was not routinely used for those found passively. The degree of smear positivity (routinely graded from +++ to scanty positive) among smear-positive cases may be a better indicator: in three studies presenting these data (conducted in South Africa, Cambodia and India), the degree of smear positivity was higher in passively diagnosed cases. CXR grading was restricted to those with CXR: all three studies reporting this found less extensive disease among screened cases. However, in none of the studies were all cases bacteriologically confi rmed, and less severe changes without independent confi rmation of TB may have other diagnoses, particularly in actively found patients. Delay is diffi cult to measure, and some studies were small, but most results were consistent with a reduction in delay.
Overall, only three studies, in India, Taiwan and Cambodia, included large numbers of cases identifi ed through screening. Therefore, although the evidence was largely consistent that screening reduces delay and leads to diagnosis of cases at an earlier stage of disease, inherent biases, such as the use of more sensitive and sometimes less specifi c diagnostic techniques in screening compared to the routine programme, would tend to give the same result. The strongest evidence comes from a comparison of the degree of smear positivity, which was lower in actively found cases.
Does screening for tuberculosis disease affect treatment outcomes?
Unpublished data from two further studies were included. As well as looking at the outcome for those who started treatment, we recorded the proportion of patients who were identifi ed but who did not register for treatment due to default, death or loss to followup ('initial defaulters'). Table 3 summarises the results from studies reporting on outcomes in TB cases identifi ed through screening (restricted to those that presented results for >10 patients). Initial default was not always reported, but was as high as a quarter of cases identifi ed through screening in the South African and Indian studies. Given the range of time periods, settings, treatment regimens, drug resistance and patients, absolute values of treatment outcome are diffi cult to compare b etween studies, but many achieved >80% successful outcomes, and the Cambodian studies >90%.
Six studies (2 in Nepal, 1 in Cambodia, 1 in India, 1 in South Africa and 1 in the Netherlands) presented comparable data on cases found through screening and passively. In all six, the outcomes for cases found through screening and PCF within each study were very similar, and this was seen in the meta-analysis: RR 1.01 (95%CI 0.99-1.04), with low heterogeneity (I 2 = 0%; Figure) . In India, subsequent studies reported initial default rates for actively and passively found cases. 68, 69 Initial default was higher in cases identifi ed through screening (29% in 1999-2001 and 24% in 2001-2002) than in passively found cases (respectively 14% and 15%). There were no deaths among the 57 actively found initial defaulters and 23 (19%) deaths among passively found initial defaulters. 68 The reasons given by the 57 patients identifi ed through screening for initial default included unwillingness to start treatment, symptoms too mild to warrant treatment, too sick, and work-related problems. 68 For all the other settings, initial default rates in passively found cases were not reported, but these can be high, and such patients have poor outcomes. [70] [71] [72] [73] [74] [75] There were many differences between the cases found through screening and passively (Tables 2 and  3) , including a tendency for cases identifi ed through screening to have less severe disease (which would tend to give lower mortality but possibly higher default rates) and to be older (which would tend to give worse outcomes). There were large differences between the six studies in the proportions with successful outcomes, but internal comparisons were consistent: treatment success was comparable in TB cases found through PCF and screening.
Figure Meta-analysis: risk ratio comparing successful treatment in cases found through screening with passively found cases. CI = confidence interval.
Table 3
Treatment outcomes of cases detected through screening and passively detected cases* Country, year, reference 
South-East Asia Region
India, 1999 44 Pulmonary 211 58 (27) 153 508 107 (70) 361 (71) 5 (3) 36 (7) 41 (27) 111 ( (69) 9 (9) 17 (11) 29 (29) 32 (20 (74) 997 (76) 5 (7) 104 (8) 13 (19) 205 ( 573 (95) 3 (0.8)
11 (2) 8 (2) 10 ( 293 (79) 1 (0.2)
12 (3) 69 (15) 63 ( 
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Length-time bias (through which slowly progressing and less severe cases with potentially higher chance of treatment success are more likely to be detected through screening than PCF) is likely in all studies comparing outcomes between screened vs. notscreened individuals. Controlled trials with comparison of treatment outcomes between the arms are required for fi rm conclusions. Only two such trials were identifi ed. In the community randomised trial in Ethiopia, the proportion successfully treated was similar in the intervention communities (81%, 128/ 159) and comparison communities (75%, 165/221), with 3% deaths in each. 22 The South African trial in infants did not fi nd any difference in mortality between infants undergoing ACF and PCF despite an increase in case detection, but overall mortality was low (<3%). 24 These studies are not included in the table or in the meta-analysis, as they used a trial design, but the fi ndings are consistent with studies for which a meta-analysis was performed.
Only one study showed a difference in mortality among TB cases identifi ed through screening compared to TB cases identifi ed through PCF. 76 In this study, among South African miners with high HIV prevalence and before the availability of antiretroviral therapy, all were screened by CXR annually. TBspecifi c mortality was 15.1 (95%CI 2.1-655) times higher in HIV-negative and 2.6 (0.7-14.9) times higher in HIV-positive TB cases identifi ed through PCF between screens compared to those identifi ed through screening. Length-time bias and residual confounding might explain part of the result.
Does screening for tuberculosis disease affect tuberculosis epidemiology in the community?
Five studies provide evidence for the effect of TB screening on the overall epidemiology of TB in the general population over several years ( Table 4) . As the interventions, assessment and settings all vary, these are discussed individually.
The community-randomised trial in Zimbabwe (DETECTB) used two different case-fi nding interventions (mobile vans or door-to-door), with the intervention contributing 37% of all smear-positive cases notifi ed during the intervention period (unpublished data). 6 There was no control group without an intervention, so for the purposes of this question the comparison of interest is the TB prevalence in the communities before and after the intervention, as assessed by prevalence surveys. This showed a 41% reduction over 3 years, after adjusting for differences between the two surveys in HIV prevalence and demography. The reduction was similar in areas covered by the different interventions, although the cumulative yield of cases during the intervention was higher in the mobile van group. The population of the area increased by 10% over the study period, and Zimbabwe experienced a A study in the United States evaluated a programme of mandatory screening and mandatory prophylaxis and treatment as indicated for those wanting to use homeless shelters. 78 Trends in TB in the whole district fell by almost 90% over 10 years. Statewide TB incidence or incidence in other areas shown were much lower, but showed no such fall. The study did not assess the effect of screening alone, and the population of the district was noted to have changed over the period due to gentrifi cation, which may have accounted for some of the fall.
DISCUSSION
This review assessed four potential benefi cial effects of screening for TB disease. The increase in TB cases and earlier diagnosis through screening could be considered intermediate outcomes. Reduction in morbidity, mortality and transmission through earlier detection and detection of cases who would otherwise remain undiagnosed are the ultimate outcomes of interest when assessing individual and community-level benefi ts. Despite extensive implementation of systematic TB screening during the last century, very few studies have primarily addressed mortality or transmission, and only one (ZAMSTAR) has had a clusterrandomised design that directly evaluated impact on TB epidemiology. The available evidence base is thus weak and shows little evidence of benefi t of systematic TB screening for individuals and communities.
There is moderate evidence to suggest that screening increases the number of cases found in the short term. The extent depends on the setting and the methods used. In many settings, more than half the prevalent TB cases in the community are undiagnosed. Targeting of some high-risk groups, or a combination of risk groups, can contribute a high proportion of cases, but targeting contacts did not contribute more than 9% of cases. It is possible that part of the impact on case detection is due to the detection of additional false-positive TB diagnoses. The proportion of false-positive cases out of all cases detected is inversely correlated with TB prevalence, and target groups for screening typically have much lower TB prevalence than people tested through PCF. A high proportion of false-positives is particularly likely when the specifi city of the fi nal diagnostic test is suboptimal. The specifi city of sputum smear microscopy ranges between 93% and 100%. [80] [81] [82] There is moderate evidence to suggest that screening tended to fi nd cases earlier and with less severe period of political unrest, factors that may have infl uenced TB prevalence
The ZAMSTAR study, conducted in communities in Zambia and South Africa, was a 2 × 2 factorial trial comparing ECF, a household intervention, both or neither. 21 The ECF sites received community mobilisation and easy access to sputum collection points either at clinics or mobile outreach activities, aiming to return results within 48 h. In the household intervention sites, households of TB patients were visited three times for education and screening for TB and HIV, and HIV-positive household members without active TB were offered isoniazid (INH) preventive therapy. The household intervention only directly saw 6% of individuals in the community. Outcomes assessed were TB prevalence from surveys, and M. tuberculosis infection incidence, assessed from tuberculin conversion in children. As shown in Table 4 , the household intervention, but not ECF, was associated with a reduction in TB prevalence. From the preliminary results (Table 4) , it seems that only 13% of patients in ECF communities were found directly through the ECF. The ZAMSTAR study has yet to be published. There were 24 communities with very varied characteristics in two countries. Restricted randomisation was used to improve balance between the trial arms. 79 With only preliminary results available, full assessment is not possible.
A follow-up study was conducted in Cambodia 2 years after a TB prevalence survey, to capture incident TB cases in community clusters screened for TB as part of the national survey. 64 The standardised TB notifi cation ratio was 0.38 (95%CI 0.27-0.52) in communities included in the national TB prevalence survey, showing a two thirds reduction in notifi cation in the study areas. Cases identifi ed during the national TB prevalence survey were not included in the calculation of the standardised TB notifi cation ratio. It is thus not clear if screening really reduced the total number of TB notifi cations or whether it simply diagnosed these cases earlier. The method used to identify all individuals treated for TB who participated in the survey is not described. It is likely that some survey participants were not identifi ed in the TB register, resulting in an underestimation of TB notifi cation among survey participants.
In Brazil, four matched pairs of communities were randomised: intervention communities received intensive household screening of contacts, including TST and INH prophylaxis. 25 Control communities received the standard DOTS package. Although this theoretically included referral of contacts for investigation, this was thought to be rare in practice, and no data on contact tracing were available. Outcomes were assessed from registration data, with the denominator from the national census. Overall, TB notifi cations decreased by 10% in the intervention communities and increased by 5% in the control communities, disease. This may partly be attributed to screening studies using more sensitive diagnostic methods than routine programmes, rather than screening per se. A recent study conducted in miners in South Africa compared 6-monthly vs. 12-monthly CXR screening (not included in this review, as it did not have a 'no screening intervention' arm). TB cases detected in the 6-monthly screening arm had less extensive disease and a lower TB-specifi c mortality compared to TB cases detected in the 12-monthly screening arm. 83 However, South African mines are a special setting, with high prevalence of both HIV and silicosis and a high risk of rapid progression to TB disease, as well as a background of ACF programmes with yearly CXR screening. It is therefore diffi cult to extrapolate these fi ndings to other settings.
Treatment outcomes for those identifi ed through screening or passively were very similar in all studies. This is surprising, as patient characteristics were different and length-time bias is likely in all studies, but the results were consistent in varied settings with different proportions of successful treatment. However, only two studies reported initial default rates in actively and passively found cases. 68, 69 It is well documented that a high proportion of passively found cases die before initiating anti-tuberculosis treatment. 68, 74, 75 'On treatment' mortality in passively found cases might thus underestimate overall mortality due to survival bias. The reasons for initial default in cases identifi ed through screening might be different: they are less symptomatic and less likely to use health care. 13, 44 The overall mortality in cases diagnosed through screening might therefore be lower than in cases diagnosed through PCF, but only one study identifi ed in this review provided data on overall mortality in adults. The South African trial in infants 24 and the community randomised trial in Ethiopia 22 both showed similar outcomes in intervention and control arms.
The evidence that screening in addition to PCF impacts on TB epidemiology remains weak, but with an insuffi cient body of evidence to allow fi rm conclusions to be drawn about absence of effect. The ZAMSTAR study provides the most thorough assessment, in challenging circumstances of high HIV prevalence. The study evaluated two different interventions (respectively TB household visits and community-wide ECF) using a factorial design, and reported a signifi cant reduction in undiagnosed TB at community level from the household intervention but not the ECF intervention. The household intervention went beyond the usual remit of TB contact tracing, with multiple visits and a strong focus on HIV as well as TB prevention, but had direct contact with only 6% of the population. Possible explanations include that the household intervention might have had extended benefi t beyond the household, through heightened awareness. ECF interventions detected only a small proportion of cases directly, and did not provide community TB screening as such, instead promoting early diagnosis through facility-based services; negative trial outcomes are therefore not necessarily generalisable to interventions using more intensive TB screening approaches. The study from Cambodia provides some evidence of reduced TB notifi cations among individuals who underwent intensive screening for TB, but the follow-up time in this study was short (2 years). 64 The study from Zimbabwe showed increased casenotifi cation rates during the study period, with a 41% reduction in TB prevalence following 3 years of implementation of community-based TB case fi nding; however, this was based on a before-after comparison with no non-intervention group to control for secular trends. 6 The main limitations of this review include a search strategy starting from a previously conducted review and high heterogeneity in screening algorithms, study setting and population. We supplemented the search strategy by contacting experts in the fi eld and authors and by conducting additional, more targeted searches. We adopted a narrative approach to account for the heterogeneity of study designs and settings, and only conducted a meta-analysis to calculate pooled risk ratios for treatment outcome. Studies showing negative or no effect of screening are less likely to be published. This is especially true for studies assessing the additional yield of screening and/or comparing treatment outcomes in actively found cases, and therefore publication bias might have infl uenced the results.
In conclusion, the evidence of individual and community-level benefi ts of systematic screening is remarkably limited, given the high public health signifi cance, long history and scale on which this approach has been implemented in the past. Large cluster randomised trials, such as the ZAMSTAR study, with long-term follow-up, would be needed to provide more evidence for such a benefi t if indeed it exists, ideally including studies that evaluate a range of interventions with different screening intensities in different epidemiological settings. In the meantime, more rigorous and consistent reporting of TB notification and mortality rates over prolonged periods of time in settings where large-scale screening programmes have been implemented should be encouraged, together with the capture of the mode of detection and other variables to support TB impact assessment. Furthermore, a better understanding of the magnitude of initial defaulting within national TB programmes is needed. This could be facilitated by including initial defaulters in the routine TB notifi cation registers. ii The International Journal of Tuberculosis and Lung Disease TST− individuals aged <30 years were not surveyed; 18% of the total population was examined annually; the screening procedure following an abnormal CXR was not described Mexico, 1995 42 Health promoters (each promoter serving 3000 individuals) were trained to identify individuals with cough. They sought out individuals at their houses, jails, shelters, orphanages, alcohol support groups and other risk groups. TB suspects were asked to attend the clinic to submit sputum samples 92 15 0.86
India, 1981 43 Lay health care workers identified TB suspects in the community, prepared microscopy slides and facilitated transport to microscopy centres. Nepal, 1990 45 Temporary microscopy camps were put up in remote villages (at an average walking time from the nearest health post of 4.25 h). Pre-camp publicity included theatre shows and house-to-house visits. 
